Showing 1 - 20 results of 51 for search 'S Kopetz', query time: 0.05s
Refine Results
-
1
-
2
-
3
Recent developments in the treatment of metastatic colorectal cancer by Jonathan M. Loree, Scott Kopetz
Published 2017-08-01
Article -
4
-
5
-
6
-
7
Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy by Li Kuiyuan, Ma Ying, Kumar Vikas, Chang David Z, Kopetz Scott
Published 2009-04-01
Article -
8
-
9
-
10
-
11
-
12
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo by Fan Fan, Susmita Ghosh, Reid Powell, Jason Roszik, Yongsun Park, Mary Sobieski, Alexey Sorokin, Clifford Stephan, Scott Kopetz, Lee M. Ellis, Rajat Bhattacharya
Published 2023-01-01
Article -
13
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo. by Fan Fan, Susmita Ghosh, Reid Powell, Jason Roszik, Yongsun Park, Mary Sobieski, Alexey Sorokin, Clifford Stephan, Scott Kopetz, Lee M Ellis, Rajat Bhattacharya
Published 2023-01-01
Article -
14
-
15
Jet Single Shot Detection by Pol Adrian Alan, Aarrestad Thea, Govorkova Katya, Halily Roi, Kopetz Tal, Klempner Anat, Loncar Vladimir, Ngadiuba Jennifer, Pierini Maurizio, Sirkin Olya, Summers Sioni
Published 2021-01-01
Article -
16
ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma. by Michael P Kim, Jason B Fleming, Huamin Wang, James L Abbruzzese, Woonyoung Choi, Scott Kopetz, David J McConkey, Douglas B Evans, Gary E Gallick
Published 2011-01-01
Article -
17
The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. by Christopher H Lieu, Hai Tran, Zhi-Qin Jiang, Muling Mao, Michael J Overman, E Lin, Cathy Eng, Jeffrey Morris, Lee Ellis, John V Heymach, Scott Kopetz
Published 2013-01-01
Article -
18
Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development by Jennifer S. Davis, Preeti Kanikarla-Marie, Mihai Gagea, Patrick L. Yu, Dexing Fang, Manu Sebastian, Peiying Yang, Ernest Hawk, Roderick Dashwood, Lenard M. Lichtenberger, David Menter, Scott Kopetz
Published 2020-09-01
Article -
19
Author Correction: Global proteomic identifies multiple cancer-related signaling pathways altered by a gut pathobiont associated with colorectal cancer by Ewa Pasquereau-Kotula, Giulia Nigro, Florent Dingli, Damarys Loew, Patrick Poullet, Yi Xu, Scott Kopetz, Jennifer Davis, Lucie Peduto, Catherine Robbe-Masselot, Philippe Sansonetti, Patrick Trieu-Cuot, Shaynoor Dramsi
Published 2023-10-01
Article -
20
The BE GONE trial study protocol: a randomized crossover dietary intervention of dry beans targeting the gut microbiome of overweight and obese patients with a history of colorecta... by Xiaotao Zhang, Gladys Browman, Wesley Siu, Karen M. Basen-Engquist, Samir M. Hanash, Kristi L. Hoffman, Pablo C. Okhuysen, Paul Scheet, Joseph F. Petrosino, Scott Kopetz, Carrie R. Daniel
Published 2019-12-01
Article